ESMO Congress 2026 brings the global oncology community to Madrid, October 23 to 27, creating a high-impact setting for biopharma companies to connect with leading clinicians, researchers, and healthcare industry stakeholders from around the world. As one of oncology’s most influential meetings, it offers a prime opportunity to engage around breakthrough data, strengthen visibility in a competitive market, and build strategic relationships across the cancer care ecosystem.
Meet our oncology experts at ESMO
Caidya’s oncology experts will be on-site throughout ESMO to connect with biopharma teams and discuss the challenges shaping oncology clinical development. Meet Adam Callahan, VP, Therapeutic Area Leader, Oncology & Hematology, Romillie Cruz, Vice President, Medical and Scientific Affairs and Etleva Pashaj, Executive Medical Director, to discuss your development plans and how Caidya’s scientific and operational expertise can support your oncology program.